Stifel Financial Corp Palatin Technologies Inc Transaction History

Stifel Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$0.68 - $1.25 $6,800 - $12,500	-10,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$0.38 - $0.78 $3,800 - $7,800	-10,000 Reduced 50.0%	10,000 $7,000
Q3 2019 Nov 13, 2019	BUY	$0.78 - $1.09 $15,600 - $21,800	20,000 New	20,000 $18,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.